Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Apellis Pharmaceuticals (APLS) Return on Assets (2020 - 2025)

Apellis Pharmaceuticals filings provide 6 years of Return on Assets readings, the most recent being 0.02% for Q4 2025.

  • For the quarter ending Q4 2025, Return on Assets rose 5.0% year-over-year to 0.02%, compared with a TTM value of 0.02% through Dec 2025, up 5.0%, and an annual FY2025 reading of 0.02%, up 5.0% over the prior year.
  • Return on Assets hit 0.02% in Q4 2025 for Apellis Pharmaceuticals, down from 0.23% in the prior quarter.
  • The five-year high for Return on Assets was 0.23% in Q3 2025, with the low at 0.78% in Q3 2021.
  • Median Return on Assets over the past 5 years was 0.35% (2024), compared with a mean of 0.35%.
  • The sharpest move saw Return on Assets crashed -43bps in 2023, then soared 57bps in 2024.
  • Year by year, Return on Assets stood at 0.45% in 2021, then tumbled by -56bps to 0.7% in 2022, then increased by 14bps to 0.6% in 2023, then surged by 96bps to 0.03% in 2024, then soared by 178bps to 0.02% in 2025.
  • According to Business Quant data, Return on Assets over the past three periods came in at 0.02%, 0.23%, and 0.07% for Q4 2025, Q3 2025, and Q2 2025 respectively.